Why the study?
Does antithrombotic prophylaxis with long term warfarin or aspirin reduce thromboembolic risk in patients with atrial fibrillation?
Does antithrombotic prophylaxis with long term warfarin or aspirin reduce thromboembolic risk in patients with atrial fibrillation?
Long-term antithrombotic prophylaxis with warfarin or aspirin is recommended to reduce thromboembolic risk in patients with atrial fibrillation, guided by clinical risk stratification.
No takes yet. Share an insight, caveat, or question.
Affirms antithrombotic benefit in AF from aggregated data; leaves open optimal strategies with contemporary agents.
Lip et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: